Manitoba Harvest Collaborates with Whole Foods Market for Nationwide Launch of Superseed Snack Clusters
Tilray's Leading Hemp Food Brand, Manitoba Harvest, Expands Superfood Portfolio with New Sweet and Salty SnacksNEW YORK, March 18, 2025 (GLOBE NEWSWIRE) -- Manitoba Harvest, the global leader in hemp foods and a Tilray Brands, Inc. company ('Tilray') (NASDAQ: TLRY and TSX: TLRY), expands into functional snacking with new Superseed Snack Clusters, now exclusively available at select Whole Foods Market stores nationwide.
Innovation Backed by Nutrition
Crafted with premium seeds, including hemp hearts, pumpkin seeds, sunflower seeds, chia and flax, Manitoba Harvest's Superseed Snack Clusters strike a perfect balance of crunchy and craveable. Enjoy convenient, guilt-free snacking with 5g of plant-based protein per serving, essential fatty acids, fiber, and key vitamins and minerals to help fuel your day.
"Our Superseed Snack Clusters are a delicious way to enjoy the benefits of hemp and other superseeds," says Jared Simon, President of Manitoba Harvest and Tilray Wellness. "Snacking should be nourishing and satisfying, and these clusters deliver on both. We're proud to collaborate with the visionary team at Whole Foods Market to bring these artisanal snacks to consumers nationwide."
Nutritional Benefits Per Serving:
5 grams of plant-based protein
5 grams of Omegas 3 & 6
2 grams of fiber
A good source of 9+ essential vitamins and minerals
Available in Three Delicious Flavors:
Maple Cinnamon – Balancing sweet maple and warm spices, these clusters are perfect alone or on top of yogurt and ice cream.
Dark Chocolate – Rich in flavor and nourishment, these Dark Chocolate and sea salt bites are satiating and satisfying for a guilt-free indulgence.
Smoky BBQ – Balancing warm heat and smoky flavors, these savory bites are a perfect match for salty snack time cravings.
Availability
Manitoba Harvest's Superseed Snack Clusters are now available exclusively on manitobaharvest.com, Amazon.com and at Whole Foods Market locations nationwide
For more information, visit www.manitobaharvest.com.
About Manitoba Harvest
Manitoba Harvest is a pioneer and leader in branded hemp-based foods and is recognized as a Certified B Corporation and the first Canadian food company to attain a Carbonzero Certification.
Taking the seed-to-shelf approach since 1998, Manitoba Harvest is committed to quality, sustainability, and consumer wellness. With an extensive product portfolio of Hemp Hearts (shelled hemp seed), Hemp Protein, Hemp Protein Blends, Hemp Granola, and Hemp Oil, Manitoba Harvest products are sold globally and in approximately 17,000 retail stores across North America.
To learn more about Manitoba Harvest and shop, visit www.manitobaharvest.com and follow @manitobaharvest across all social platforms.
About Tilray Brands
Tilray Brands, Inc. ('Tilray') (Nasdaq: TLRY; TSX: TLRY), is a global lifestyle and consumer packaged goods company at the forefront of beverage, cannabis and wellness industries with operations in Canada, the United States, Europe, Australia, and Latin America that is leading as a transformative force at the nexus of cannabis, beverage, wellness, and entertainment, elevating lives through moments of connection. Tilray's mission is to be a leading premium lifestyle company with a house of brands and innovative products that inspire joy, wellness and create memorable experiences. Tilray's unprecedented platform supports over 40 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and craft beverages.
For more information on Tilray Brands, visit www.Tilray.com and follow @Tilray.
Forward-Looking Statements
Certain statements in this communication that are not historical facts constitute forward-looking information or forward-looking statements (together, 'forward-looking statements') under Canadian and U.S. securities laws and within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be subject to the 'safe harbor' created by those sections and other applicable laws. Forward-looking statements can be identified by words such as 'forecast,' 'future,' 'should,' 'could,' 'enable,' 'potential,' 'contemplate,' 'believe,' 'anticipate,' 'estimate,' 'plan,' 'expect,' 'intend,' 'may,' 'project,' 'will,' 'would' and the negative of these terms or similar expressions, although not all forward-looking statements contain these identifying words. Certain material factors, estimates, goals, projections, or assumptions were used in drawing the conclusions contained in the forward-looking statements throughout this communication. Forward-looking statements include statements regarding our intentions, beliefs, projections, outlook, analyses, or current expectations. Many factors could cause actual results, performance, or achievement to be materially different from any forward-looking statements, and other risks and uncertainties not presently known to the Company or that the Company deems immaterial could also cause actual results or events to differ materially from those expressed in the forward-looking statements contained herein. For a more detailed discussion of these risks and other factors, see the most recently filed annual information form of Tilray and the Annual Report on Form 10-K (and other periodic reports filed with the SEC) of Tilray made with the SEC and available on EDGAR. The forward-looking statements included in this communication are made as of the date of this communication and the Company does not undertake any obligation to publicly update such forward-looking statements to reflect new information, subsequent events, or otherwise unless required by applicable securities laws.
For further information, please contact
Media: news@tilray.com Investors: investors@tilray.com
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/ad544286-0323-4bb3-a93d-50ba6d4d2ef7
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Yahoo
32 minutes ago
- Yahoo
Nvidia GTC Paris is 'another bullish proof point' long term
-- Nvidia's GTC conference in Paris offered no stock-moving announcements but added further evidence of long-term growth, Morgan Stanley said in a note this week, calling it 'another bullish proof point for Nvidia's business beyond 2025.' The firm highlighted that 'European catch-up investment, quantum/classical opportunities, and industrial/physical AI were the main focus,' all of which provide 'incremental growth' on top of the broader AI boom. At the event, Nvidia (NASDAQ:NVDA) emphasized accelerating EU investment. 'Earlier this year the EU launched a €200 billion initiative for AI investment,' with €20 billion earmarked to help finance five AI gigafactories. Nvidia's own announcements included plans requiring 'more than 3,000 exaflops of NVIDIA Blackwell compute,' including 'an 18k GB200 phase one deployment with Mistral in France' and 'a 14k Blackwell development in the UK.' The company also plans to build 'the world's first industrial AI cloud for European manufacturers' and new AI centers across Germany, Sweden, Italy, Spain, the U.K. and Finland. Morgan Stanley said the keynote reflected Nvidia's shift toward 'robotics and physical AI,' noting, 'investment is happening now.' The firm estimates European GPU revenue could grow '8x or more from CY24 to CY26.' CEO Jensen Huang was said to have been 'more constructive on a timeline for hybrid GPU/QPU systems' and reiterated Nvidia's strategy of complementing quantum computing with classical simulation tools. Nvidia also expanded its DGX Cloud Lepton marketplace with AWS and Azure joining smaller compute providers, aiming to 'make it easier for developers to manage, monitor, and deploy their compute resources globally.' Despite management's usual conservative tone, Morgan Stanley said, 'We would characterize management as highly confident,' adding that 'NVIDIA is outgrowing ASIC competitors meaningfully.' The firm reiterated its Overweight rating and kept Nvidia as its 'Top Pick in semis.' Related articles Nvidia GTC Paris is 'another bullish proof point' long term - Morgan Stanley stocks of the week What are the current theme park trends? Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
If I Could Buy Only 1 Artificial Intelligence Stock Over the Next Year, Amazon Would Be It, but Here's the Key Reason
There are several reasons to like Amazon as a long-term investment right now. AWS could be a particularly massive growth driver for the rest of the decade and beyond. The cloud computing business could drive market-beating performance all by itself. 10 stocks we like better than Amazon › There are some excellent artificial intelligence (AI) stocks you can buy right now. However, my favorite -- and largest AI play in my own portfolio -- is Amazon (NASDAQ: AMZN). To be sure, there are a lot of reasons why I like Amazon as a long-term investment. E-commerce still represents less than one-fifth of all U.S. retail, and there's massive international expansion potential for the business, just to name a few pluses. But the No. 1 reason I love the stock is Amazon Web Services (AWS) and its potential to drive profits higher over the next decade. AWS makes up less than 20% of Amazon's revenue, but it's the fastest-growing, most profitable part of the company. Despite accounting for less than one-fifth of sales, as noted, AWS was responsible for 63% of the company's operating income in the first quarter. However, this could be just the beginning. The global cloud computing market is expected to roughly triple in size by 2030, compared with 2024 levels. Assuming AWS simply maintains its current market share, this means that AWS revenue could rise from $107.6 billion in 2024 to about $342 billion in 2030. If Amazon can maintain its current operating margin for AWS (it's likely the margin will improve as the business scales), this would result in about $87 billion in additional annual operating income just from AWS. This alone would likely drive excellent stock returns -- and that's on top of any value added through profit increases from the retail side. Before you buy stock in Amazon, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Amazon wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $657,871!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $875,479!* Now, it's worth noting Stock Advisor's total average return is 998% — a market-crushing outperformance compared to 174% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 9, 2025 John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. Matt Frankel has positions in Amazon. The Motley Fool has positions in and recommends Amazon. The Motley Fool has a disclosure policy. If I Could Buy Only 1 Artificial Intelligence Stock Over the Next Year, Amazon Would Be It, but Here's the Key Reason was originally published by The Motley Fool Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
an hour ago
- Yahoo
CEO & Director of Aytu BioPharma Joshua Disbrow Buys 77% More Shares
Even if it's not a huge purchase, we think it was good to see that Joshua Disbrow, the CEO & Director of Aytu BioPharma, Inc. (NASDAQ:AYTU) recently shelled out US$100k to buy stock, at US$1.50 per share. Even though that isn't a massive buy, it did increase their holding by 77%, which is arguably a good sign. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. In fact, the recent purchase by Joshua Disbrow was the biggest purchase of Aytu BioPharma shares made by an insider individual in the last twelve months, according to our records. Even though the purchase was made at a significantly lower price than the recent price (US$1.95), we still think insider buying is a positive. Because it occurred at a lower valuation, it doesn't tell us much about whether insiders might find today's price attractive. Aytu BioPharma insiders may have bought shares in the last year, but they didn't sell any. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. By clicking on the graph below, you can see the precise details of each insider transaction! See our latest analysis for Aytu BioPharma Aytu BioPharma is not the only stock that insiders are buying. For those who like to find small cap companies at attractive valuations, this free list of growing companies with recent insider purchasing, could be just the ticket. Many investors like to check how much of a company is owned by insiders. I reckon it's a good sign if insiders own a significant number of shares in the company. From looking at our data, insiders own US$500k worth of Aytu BioPharma stock, about 2.9% of the company. We prefer to see high levels of insider ownership. The recent insider purchases are heartening. And the longer term insider transactions also give us confidence. But we don't feel the same about the fact the company is making losses. On this analysis the only slight negative we see is the fairly low (overall) insider ownership; their transactions suggest that they are quite positive on Aytu BioPharma stock. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Aytu BioPharma. Be aware that Aytu BioPharma is showing 3 warning signs in our investment analysis, and 2 of those can't be ignored... But note: Aytu BioPharma may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt. For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio